Skip to content

Thrombectomy in ST Elevation Myocardial Infarction, an Individual Patient Meta-analysis

Thrombectomy in ST Elevation Myocardial Infarction, an Individual Patient Meta-analysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02552407
Enrollment
18000
Registered
2015-09-17
Start date
2015-09-30
Completion date
2016-11-30
Last updated
2017-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndromes, Myocardial Infarction

Keywords

thrombectomy, acute coronary syndromes, percutaneous coronary intervention, STEMI

Brief summary

During primary percutaneous coronary intervention, distal embolization of thrombus and impaired microvascular perfusion has been associated with an increased mortality. Thrombectomy devices during primary percutaneous coronary intervention may prevent distal embolization by reducing thrombus burden and thus improve microvascular perfusion and reduce mortality.

Detailed description

An individual patient meta-analysis of large randomized controlled trials comparing manual thrombectomy versus percutaneous coronary intervention alone in patients with ST elevation myocardial infarction will provide significantly more power to detect differences in mortality as well as important but rare events such as stroke and to assess benefits in pre-defined subgroups.

Interventions

DEVICEManual Aspiration Thrombectomy

Thrombus aspiration

Sponsors

Uppsala University
CollaboratorOTHER
Region Örebro County
CollaboratorOTHER
University Medical Center Groningen
CollaboratorOTHER
University of Groningen
CollaboratorOTHER
Population Health Research Institute
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Randomized controlled trials comparing manual thrombectomy vs. percutaneous coronary intervention alone in patients with ST elevation myocardial infarction published between January 1980 and April 2015. * Large trials randomizing more than 1000 patients. * Trials must have had at least 30 day follow up.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of Cardiovascular deathup to 30 daystime to event analysis

Secondary

MeasureTime frameDescription
Occurrence of Cardiovascular deathup to 180 daystime to event analysis

Other

MeasureTime frameDescription
Occurrence of Strokeup to 30 daystime to event analysis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026